Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies-Reference-Cited by-同舟云学术

Targeting the T cell receptor β-chain constant region for immunotherapy of T cell malignancies

Published:2017-11-13 Issue:12 Volume:23 Page:1416-1423
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Maciocia Paul M,Wawrzyniecka Patrycja A,Philip Brian,Ricciardelli Ida,Akarca Ayse U,Onuoha Shimobi C,Legut Mateusz,Cole David K,Sewell Andrew K^ORCID,Gritti Giuseppe,Somja Joan,Piris Miguel A,Peggs Karl S,Linch David C,Marafioti Teresa,Pule Martin A^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.4444.pdf

Reference36 articles.

1. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. Blood 89, 3909–3918 (1997).

2. Vose, J., Armitage, J., Weisenburger, D. & International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J. Clin. Oncol. 26, 4124–4130 (2008).

3. Weisenburger, D.D. et al. Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project. Blood 117, 3402–3408 (2011).

4. Gao, G. et al. A systematic review and meta-analysis of immunochemotherapy with rituximab for B-cell non-Hodgkin's lymphoma. Acta Oncol. 49, 3–12 (2010).

5. Bargou, R. et al. Tumor regression in cancer patients by very low doses of a T cell–engaging antibody. Science 321, 974–977 (2008).

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Abnormal Cellular Populations Shape Thymic Epithelial Tumor Heterogeneity and Anti‐Tumor by Blocking Metabolic Interactions in Organoids;Advanced Science;2024-09-11

2. “Clone-specific” antibody-drug conjugates: an innovative strategy in the treatment of T-cell cancers;Signal Transduction and Targeted Therapy;2024-09-04

3. Fratricide-resistant CD7-CAR T cells in T-ALL;Nature Medicine;2024-09-03

4. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia;2024-09-03

5. T cell receptor-directed antibody-drug conjugates for the treatment of T cell-derived cancers;Molecular Therapy: Oncology;2024-09